- Home
- BNTX vs DVN Comparison
BNTX vs DVN Comparison
Compare BNTX & DVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BNTX | DVN |
|---|---|---|
| Founded | 2008 | 1971 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.9B | 56.0B |
| IPO Year | 2019 | 1999 |
Fundamental Metrics
Financial Performance| Metric | BNTX | DVN |
|---|---|---|
| Price | $85.42 | $46.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 28 |
| Target Price | ★ $113.11 | $60.52 |
| AVG Volume (30 Days) | 975.2K | ★ 10.4M |
| Earning Date | 11-03-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 2.77% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.36 |
| Revenue | N/A | ★ $17,188,000,000.00 |
| Revenue This Year | N/A | $60.84 |
| Revenue Next Year | $0.50 | $6.71 |
| P/E Ratio | ★ N/A | $13.71 |
| Revenue Growth | N/A | ★ 7.83 |
| 52 Week Low | $79.81 | $34.23 |
| 52 Week High | $124.00 | $52.71 |
Technical Indicators
Market Signals| Indicator | BNTX | DVN |
|---|---|---|
| Relative Strength Index (RSI) | 40.36 | 46.87 |
| Support Level | $79.81 | $44.89 |
| Resistance Level | $93.48 | $46.54 |
| Average True Range (ATR) | 2.52 | 1.65 |
| MACD | 0.09 | -0.31 |
| Stochastic Oscillator | 18.05 | 49.79 |
Price Performance
Historical ComparisonAbout BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
About DVN Devon Energy Corporation
Devon Energy is an oil and gas producer with acreage in several top US shale plays. While roughly two-thirds of its production comes from the Permian Basin, it also holds a meaningful presence in the Anadarko and Bakken basins. After the merger with Coterra, it will have a foothold in the gas-driven Appalachian Basin as well. At the end of 2025, Devon reported net proved reserves of 2.4 billion barrels of oil equivalent, up from 2.2 billion in 2024. Net production averaged roughly 840,000 barrels of oil equivalent per day in 2025 at a ratio of 73% oil and natural gas liquids and 27% natural gas.